Li Zuo
Appearances
DateMay 18, 2024Immune checkpoint inhibitors (ICIs), such as anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and anti-programmed cell death protein 1 (PD-1), have revolutionized cancer treatment and survival. However, ICIs can lead to immune-related adverse events, notably colitis…
DateMay 18, 2024MECHANOGATED ION CHANNEL PIEZO2 TETHERS TO THE ACTOMYOSIN CYTOSKELETON IN INTESTINAL EPITHELIAL MECHANORECEPTORSModerators
University of MichiganVanderbilt University Medical CenterSpeakers
Cincinnati Children's Hospital Medical Center
